Archives: 4/2006

421235 The CereTom™ Mobile CT Scanner
CereTom™ by NeuroLogica Corp. (Danvers, MA), is a winner of the Medical Design Excellence Award in the radiological devices category this year. The company says that its system is the world’s first cordless and wireless head and neck mobile CT. The system can be used in on-the-go locations, such as bedside, ER, ICU and even in private offices. According to NeuroLogica, the CereTom™ Mobile CT is “optimized for scanning anatomy that can be imaged in the 25 cm field of view, primarily head and neck. It is capable of performing non contrast CT, CT angiography and CT Perfusion. The system generates up to 8 slices per revolution, using a Modular Multi-Row Detector (MMD).”
Systems components (see numbers in the picture):

1. Bore Sized to Accommodate Heads with Room for Masks, ICPs, Bandages, etc.
2. Scan Plane is Close to Outer Surface to Allow Scanning of the Neck.
3. Battery Compartment.
4. Patented “Centipede” Drive System Moves the CT Over the Patient.
5. Dual Stainless Steel Handles for Ergonomic Transport.
6. Easy to Use Color Touch Screen LCD, which is movable and tiltable.

431235 The CereTom™ Mobile CT Scanner
System homepage
Company press release
Medical Design Excellence Award winners
Flashback: We have covered the CereTom™ CT in our earlier post

125123 Artificial Compound Eye for Future Medical Scopes
UC Berkeley scientists, using an insect eye as a prototype, have created an artificial compound eye that one day might make it to endoscopes, laparoscopes and other equipment. According to UC Berkeley, such an artificial eye system will allow a “wider field of vision than previously possible, even with the best fish-eye lens”:

They are the first hemispherical, three-dimensional optical systems to integrate microlens arrays – thousands of tiny lenses packed side by side – with self-aligned, self-written waveguides, that is, light-conducting channels that themselves have been created by beams of light, said Lee, the Lloyd Distinguished Professor of Bioengineering at UC Berkeley.
The eyes are fully described for the first time in the April 28 issue of the journal Science.
“I’ve always wanted to create an advanced, three-dimensional optical system,” Lee said, “but conventional microfabrication technology is two-dimensional. So, I started thinking about basing a fabrication system on the developmental stages of insect eyes that I’d learned about as a biophysicist and bioengineer.”
What he and his team came up with is a low-cost, easy-to-replicate method of creating pinhead-sized polymer resin domes spiked with thousands of light-guiding channels, each topped with its own lens. Not only are these units packed together in the same hexagonal, honeycomb pattern as in an insect’s compound eye, but each is also remarkably similar in size, design, shape and function to an ommatidium, the individual sensory unit of a compound eye.
While conventional microfabrication techniques are expensive and use high temperatures, Lee and his team borrowed from nature, using a low temperature system, photopolymerization, and self-aligning, self-writing technology.
To create the artificial eye, the team first needed to construct a hemispherical mold of the eye’s outer layer, a structure consisting of thousands of microlenses. Using existing technology, they made a flat array of these tiny, domed lenses arranged in the hexagonal honeycomb pattern. On top of this, they applied a thin slab of an elastic polymer called polydimethylsiloxane, or PDMS, creating a concave pattern of the lenses in the polymer. By affixing the PDMS membrane over the opening of a vacuum chamber and applying negative air pressure, they pulled it into the dome shapes they needed, controlling its form by using different pressures.
They then had a hemisphere-shaped cup pocked with some 8,700 indentations: a compound-eye mold that could be used over and over again using soft lithography technology, a set of methods developed over the last decade to replicate nanoscale-sized structures.
The material they chose for the artificial eyes was an epoxy resin that cures into a hardened form when exposed to ultraviolet light. They poured the resin into the dimpled molds, baked it at a low temperature just long enough to slightly harden the material, then turned out the contents: little resin hemispheres with a surface packed with 8,700 raised mounds. When struck by a beam of light, each of these mounds acts as a lens, focusing the light and sending it into the material below. Like a welder’s torch burning a hole into metal, over time the focused light beams etch holes in the resin creating the tiny channels called self-written waveguides.
Because these channels are formed at the angle of the light beams that strike them, Lee used a condenser lens to bend his light source into a spoke-like pattern of beams that converges on the eye’s dome. The end result is that the waveguides pierce the resin at angles that head toward the center of the dome, just like the converging ommatidia of an insect eye.
Because the microlenses create the waveguides, each microlens is perfectly aligned with its waveguide. The self-alignment, self-writing processes are crucial to the creation of the artificial compound eye, said Lee, because these processes will also align the microlenses and waveguides with the pixels of CCDs and spectroscopes.

125125 Artificial Compound Eye for Future Medical Scopes

Caption: (A) Spherical arrangement of artificial ommatidia on hemispherical polymer dome of 2.5 mm in diameter with artificial ommatidia of 8,370 and (B) a cross-section image with the spherical arrangement of artificial ommatidia consisting of microlenses, polymer cones, and waveguide arrays, and (C) a confocal micrograph of the backside of an artificial compound eye showing microlenses, polymer cones and polymer waveguides.

The press release
The BioPOETS (Biomolecular Polymer Opto-Electronic Technology and Science) group website

A group of European scientists has developed a nano-switch touted to provide a link between biological and silicon worlds, with a wide range of possible future uses. From the EU’s CORDIS News Service:

The project itself is rather difficult to conceptualise: a ‘nano-actuator’ device so small that it could be used to move specific DNA fragments, and allow individual DNA sequencing. The project’s aim was to produce an individual molecular ‘nano-switch’…
The researchers used a type of molecular motor known as a ‘Restriction-Modification enzyme’. This molecular motor attaches itself only to specific sequences of A, C, G and T. ‘This binding is very specific, a motor will bind only with its corresponding bases, so you can control exactly where the motor is placed on the vertical DNA strand,’ said Dr Firman.
The DNA strand is held upright by a magnetic field, pulling a magnetic marker at the end of the DNA strand. The molecular motor sits somewhere below the magnetic marker at a specific position, and does not move. When the molecular engine is started, when fed biological fuel ATP, it pulls the DNA strand, stopping when it reaches the magnetic marker.
Why does this matter, and what use is this? Most simply, this nano-switch enables one form of energy to be transferred to another for a useful purpose, and in a controlled fashion. ‘The light switch, the button that makes a retractable pen, all these are actuators, and by developing a molecular switch we’ve created a tiny actuator that could be used in an equally vast number of applications,’ says Dr Firman.
The result is quite literally a building-block for the nano-world, and as the imaginations of researchers grow, so will useful applications of the switch. ‘It could be used as a communicator between the biological and silicon worlds. I could see it providing an interface between muscle and external devices, through its use of ATP, in human implants. Such an application is still 20 or 30 years away,’ says Dr Firman ‘It’s very exciting and right now we’re applying for a patent for the basic concepts.’
One unintended by-product of this research is in DNA sequencing. If the DNA strand is marked with fluorescence, then ‘Knowing the speed of the motor, which is quite reliable and steady at any specific temperature, we could locate the position of the DNA-based Fluor [molecule] relative to the binding site of the motor,’ says Dr Firman. ‘More work needs to be done. However, the concept is sound and we now have enough evidence to indicate that this could be used to sequence single-nucleotide polymorphisms (SNPs) that cause genetic disorders.’

The report
Project page (featuring video)…

This morning, Medgadget.com along with a number of other blogs, suffered a Denial of Service attack (DoS). Kevin M.D., Instapundit, and a number of other sites were victims of the attack. According to sources at Hosting Matters, our server host, the DoS originated in the friendly kingdom of Saudi Arabia. Perhaps this might be a good time to get those 5 gallon NATO gas canisters and stock up on the ol’ petrol for the long, hot summer.
Wikipedia: DoS attack

541432 PDA Software to Help in a Mined FieldThe Business Edge from Ontario, O’Canada is reporting that a Vancouver-based company, NGRAIN Corp., has developed PDA-based software to help soldiers in the field to navigate around or to disarm land mines. Not a medgadget per se, but if it is saving lives, then it might as well be covered by us. From the company, about its cooperation with the O’Canada National Defence Mine/Countermine Information Centre (O’NDMIC):

The NGRAIN solution will assist the Canadian Forces with deploying mission critical NDMIC information on foreign anti-personnel and anti-tank mines accurately and safely to soldiers in field operations and those in mine awareness training.
“With NGRAIN, the speed at which interactive 3D content can be produced, distributed, and viewed means that Canadian Forces personnel have the tools necessary to execute the mission where and when needed,” said Master Warrant Officer Tom Stewart, Canadian Forces, J3 Engineer Operations. “The advent of the R-PDA capability represents a tremendous leap forward in our ability to provide first-class information that is unequalled by any other country and accessible anywhere, anytime, resulting in reduced safety risks through better training and instant access to critical information in the field.”
Soldiers will be able to search the Canadian Forces landmine database on an R-PDA. Soldiers will be able to interact with 3D landmine objects from many angles, including the ability to view all internal components in context with the CFLD database of valuable information related to the mines.
“Our high level of innovation is continually elevated by the demands of our customers in the military. Currently, NGRAIN provides the capability for soldiers to interact with 3D landmine objects on their desktop, laptop, or Tablet computers. Through this contract, the Department of National Defence requires this same capability in the field on R-PDA’s, so we will deliver a solution to meet their critical needs in training as well as field operations,” said Joseph Bailey, Vice President, Sales at NGRAIN.

Want more info? Read the article
Company’s statement

medtronic soletra Deep Brain Stimulation Shows Promise in Treatment of Obsessive Compulsive DisorderDeep brain stimulation (DBS) is gaining momentum as a promising therapeutic technique for a number of psychiatric disorders. You can recall that when we covered Kinetra® Dual-Channel Neurostimulator (Medtronic, Inc.) almost a year ago, we mentioned early reports of the stimulator’s effectiveness for treatment-resistant depression.
This report by the American Association of Neurological Surgeons, from its annual meeting, shows that the technique could be useful for obsessive compulsive disorder (OCD):

DBS has been used to treat intractable pain for several decades, and more recently, use of this technology has expanded to the FDA-approved indications for Parkinson’s disease and other movement disorders. DBS is also under investigation in the treatment of epilepsy and other debilitating neurological conditions. DBS surgery involves the placement of tiny implantable electrodes into specific parts of the brain that are functioning abnormally. These electrodes emit tiny pulses of electrical stimulation to block the abnormal activity in the brain, which causes a variety of symptoms – such as pain, tremors, movement problems; as well as obsessions, moods and anxieties associated with psychiatric disorders. The success of DBS is dependent on the surgical team’s ability to precisely pinpoint the specific brain area for stimulation. The advantage of DBS is that it is reversible, nondestructive, and can be modified by adjustment of the stimulator settings after implantation.
This study was conducted with Institutional Review Board (IRB) and Food and Drug Administration (FDA) Investigational Device Exemptions (IDE) approval. Six patients, four females and two males, with an average age of 48, were enrolled in the study from 2003 to 2005. All six patients had a history of being highly resistant to other treatments, including medication, psychotherapy, and electroconvulsive therapy (ECT). Bilateral DBS leads were implanted stereotactically in a region of the brain known as the ventral anterior internal capsule. Participants underwent standardized and detailed psychiatric, quality-of-life, and neuropsychological assessments on a regularly scheduled basis, both pre- and postsurgically.
At a minimum of six months postsurgery, four of the six patients showed a clinically significant reduction in depression severity of 50 percent or greater on the Montgomery-Asberg Depression Rating Scale. Quality-of-life measures improved as well, and patients showed progressive improvements in mood and functioning over time. One patient experienced persistent occipital pain that was alleviated with repositioning of a subcutaneous connector wire.

We are not aware of other manufacturers, except for Medtronic, making deep brain stimulators. Are you? If so, please let us know in the comments section.
The report

13116 The Delphi IVantage™ Infusion PumpThe Delphi IVantage™ Infusion Pump is a winner of the Medical Design Excellence Award in the general hospital device and therapeutic product category. According to the award press release, this programmable infusion system incorporates a rotary cassette as an anti-free-flow protection device.
From Delphi Technologies, Inc., a Troy, Michigan company, the maker of the device:

The Delphi IVantage™ Infusion Pump is a portable, simple-to-use rotary peristaltic volumetric infusion pump that weighs only 13 ounces (including battery). Yet it performs competitively with products many times its size and weight. It is fully configured to send and receive data over the Remote Device Connectivity network…
The unique design of the IVantage™ Infusion Pump allows IV solutions to be administered consistently and accurately across a wide flow-rate range (0.1 ml/h to 999 ml/h). This is achieved by using a precision disposable rotary peristaltic mechanism that also does not require any specific orientation to the patient or to the fluid source. Multiple alarm capabilities and software control parameters can be selected by clinicians to support specialized therapies…
The pump can be powered using a standard AC adapter or a built-in, rechargeable battery (up to 22 hours on)-providing flexibility and backup capabilities for enhanced ambulatory use. It can be easily toted via a shoulder strap or belt clip, thus increasing mobility for patients at home…
In addition to portability, the Delphi IVantage™ Infusion Pump sports a host of innovative features and benefits. The disposable, integrated compact rotary mechanism and infusion set facilitates an easy-to-prime, sterile, and closed connection between the electronic pump and the patient. The infusion set also incorporates an innovative sliding mechanism to help prevent free-flow whenever the set is removed from the pump. The rotary mechanism incorporates a transparent case so that actual roller operation can be viewed during the infusion process.

The product page
Medical Design Excellence Award winners

45t2344 The IGI System for Dental Surgery NavigationWe are continuing our coverage of this year’s Medical Design Excellence Awards. One of the two winners in the dental category was DenX Advanced Dental Systems Ltd., a Jerusalem, Israel based company. According to a press release, its IGI system for surgical navigation “assists in the preoperative and intraoperative phases of dental implantation surgery, accurately guiding surgical instruments according to a CT-based presurgical plan.”
Here is the company on its product:
7654545 The IGI System for Dental Surgery Navigation

With IGI, the dental clinician can be assured of a comprehensive navigational solution where:
- pre-surgical planning matches the surgical performance
- critical structures are accurately defined and avoided
- the implant is precisely placed and
-on-line treatment, follow up and data storage are provided…
IGI is an interactive and extremely easy to operate dual processor workstation. Careful ergonomic design ensures that the system fits easily into any dental office. IGI is composed of a high powered computerized workstation, an extremely accurate motion tracking system, high resolution imaging data and precise localization devices.
1643215 The IGI System for Dental Surgery NavigationFirst, a virtual implant is placed on the CT image with the assistance of IGI’s advanced planning tools. During the surgical procedure, the clinician is navigating the implant to the precise location, angle and depth required according to the plan. Real-time localization feedback assisted by audio and visual media allows the clinician to monitor the success of the procedure and avoid critical mistakes at all times.
The clinician is able to achieve the highest level of accuracy and certainty possible when performing implant surgery, by superimposing the virtual and actual images. Minimal invasive surgery is performed with enhanced assurance and efficiency.

To read more about the system, visit the product page
Medical Design Excellence Award winners

241424 Medical Heart Pumps from HeartWare: HVAD, MVAD and PedVADThe Sydney Morning Herald is reporting that a local company HeartWare Ltd., is developing “the smallest of the third generation left ventricular assist devices (LVAD) available in the market, and being the smallest is very big news.” The newspaper also reports that the firm has implanted its HVAD, a left ventricular assist device, into a 48 year old Austrian patient with heart failure.
Here is how the company describes its technology:

HeartWare’s technology is based on the use of a wide bladed impeller designed to achieve optimum performance and haemocompatibility, size minimisation, long term reliability and overall system efficiencies.
The impeller is the only moving part in the HeartWare device. The impeller is held in place by a proprietary hybrid magnetic and hydrodynamic bearing system. The wide blades of the impeller contain large motor magnets, so the same space is used for pump and motor elements, achieving design efficiencies. The rare earth magnets in the impeller do not require electricity in order to induce their magnetic effect, thereby minimising the need for wires and connections, further simplifying the design and improving reliability. The result is a compact, energy efficient device, wearless, reliable and shock resistant, and designed to provide full cardiac output with optimal haemocompatibility.
341424 Medical Heart Pumps from HeartWare: HVAD, MVAD and PedVAD
Important additional features of the technology include two motor stators providing redundancy, a proprietary integrated inflow cannula enabling pericardial implantation, and electrical leads based on pacemaker technology.

Even though it is not clear to us how the device is attached to the heart or aorta (or else), here is some information about the HVAD:

With a volume of only 45cc, the HVAD is the smallest full output long term circulatory assist device under development. HeartWare believes the HVAD to be the only device of its type that can be implanted in the space directly surrounding the heart, rather than in the abdomen. This leads to significant potential advantages, particularly in terms of the ease of surgical implantation and consequent patient benefits.

We also understand that the company is trying to bring to the market another miniaturised ventricular assist device (named MVAD) and a pedi version, the PedVAD, for infants with heart failure.
Company website
The Sydney Morning Herald article